tirzepatide doses (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects Tirzepatide Dosage Guide 2025: Effective

doi:10.1016/j.cbi.2008.10.040 33

It should be noted that these findings do not imply that DPP-4 inhibitors are harmful in any way or that GLP-1 drugs are definitely beneficial for brain health. Kornelius also noted that tirzepatide, a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, was not evaluated since it was approved after the beginning of the study period.

Looking back, that's totally wrong, of course

In light of this theoretical and early-stage framework, the phase 3 SURPASS clinical trials program is exploring the efficacy and safety of tirzepatide in patients with T2D (Figure 4), and results from some of these trials have been recently published

These are sourced from a top-quality pharma devices manufacturer in China.